We compared whole-exome sequencing (WES) and whole-genome sequencing (WGS) for the detection of single-nucleotide variants (SNVs) in the exomes of six unrelated individuals. In the regions targeted by exome capture, the mean number of SNVs detected was 84,192 for WES and 84,968 for WGS. Only 96% of the variants were detected by both methods, with the same genotype identified for 99.2% of them. The distributions of coverage depth (CD), genotype quality (GQ), and minor read ratio (MRR) were much more homogeneous for WGS than for WES data. Most variants with discordant genotypes were filtered out when we used thresholds of CD≥8X, GQ≥20, and MRR≥0.2. However, a substantial number of coding variants were identified exclusively by WES (105 on average) or WGS (692). We Sanger sequenced a random selection of 170 of these exclusive variants, and estimated the mean number of false-positive coding variants per sample at 79 for WES and 36 for WGS. Importantly, the mean number of real coding variants identified by WGS and missed by WES (656) was much larger than the number of real coding variants identified by WES and missed by WGS (26). A substantial proportion of these exclusive variants (32%) were predicted to be damaging. In addition, about 380 genes were poorly covered (~27% of base pairs with CD<8X) by WES for all samples, including 49 genes underlying Mendelian disorders. We conclude that WGS is more powerful and reliable than WES for detecting potential disease-causing mutations in the exome.
Introduction
Whole-exome sequencing (WES) is now routinely used for detecting rare and common genetic variants in humans (1) (2) (3) (4) (5) (6) (7) . Whole-genome sequencing (WGS) is becoming an attractive alternative approach, due to its decreasing cost (8, 9) . However, it remains difficult to interpret variants lying outside the coding regions of the genome. Diagnostic and research laboratories, whether public or private, therefore tend to search for coding variants, which can be detected by WES, first. Such variants can also be detected by WGS, but few studies have compared the efficiencies of WES and WGS for this specific purpose (10) (11) (12) . Here, we compared WES and WGS for the detection and quality of single-nucleotide variants (SNVs) located within the regions of the human genome covered by WES, using the most recent next-generation sequencing (NGS) technologies. Our goals were to identify the method most efficient and reliable for identifying SNVs in coding regions of the genome, to define the optimal analytical filters for decreasing the frequency of false-positive variants, and to characterize the genes that were hard to sequence by either technique.
Results
To compare the two NGS techniques, we performed WES with the Agilent Sure Select Human All Exon kit 71Mb (v4 + UTR), and WGS with the Illumina TruSeq DNA PCR-Free sample preparation kit on blood samples from six unrelated Caucasian patients with isolated congenital asplenia (OMIM #271400). We used the genome analysis toolkit (GATK) bestpractice pipeline for the analysis of our data (13) . We used the GATK Unified Genotyper (14) to call variants, and we restricted the calling process to the regions covered by the Sure Select Human All Exon kit 71Mb plus 50 bp of flanking sequences on either side of the each of the captured regions, for both WES and WGS samples. These regions, referred to as the WES71+50 region, included 180,830 full-length and 129,946 partial protein-coding exons from 20,229 genes (Table S1 ). There were 65 million reads per sample, on average, mapping to this region in WES, corresponding to a mean coverage of 73X (Table S2) , consistent with the standards set by recent large-scale genomic projects aiming to decipher disease-causing variants by WES (11, 14, 15) . On average, 35 million reads per sample mapped to this region by WGS, corresponding to a mean coverage of 39X (Table S2 ). The mean (range) number of SNVs detected was 84,192 (82,940-87,304) per exome and 84,968 (83,340-88,059) per genome. The mean number of SNVs per sample called by both methods was 81,192 (~96% of all variants) ( Fig. S1A) . For 99.2% of these SNVs, WES and WGS yielded the same genotype, and 62.4% of these concordant SNVs were identified as heterozygous (Fig. S1B) . These results are similar to those obtained in previous WES studies (1, 5, 16) . Most of the remaining SNVs (329 of 415) with discordant genotypes for these two techniques, were identified as homozygous variants by WES and as heterozygous variants by WGS. A smaller number of variants (86, on average), were identified as heterozygous by WES and homozygous by WGS ( Fig. S1B) .
We then investigated in WES and WGS data the distribution of the two main parameters assessing SNV quality generated by the GATK variant calling process (14) : coverage depth (CD), corresponding to the number of aligned reads covering a single position; and genotype quality (GQ), which ranges from 0 to 100 (higher values reflect more accurate genotype calls).
We also assessed the minor read ratio (MRR), which was defined as the ratio of reads for the less covered allele (reference or variant allele) over the total number of reads covering the position at which the variant was called. Overall, we noted reproducible differences in the distribution of these three parameters between WES and WGS. The distribution of CD was skewed to the right in the WES data, with a median at 50X but a mode at 18X, indicating low levels of coverage for a substantial proportion of variants ( Fig. 1A) . By contrast, the distribution of CD was normal-like for the WGS data, with the mode and median coinciding at 38X (Fig. 1A) . We found that 4.3% of the WES variants had a CD < 8X, versus only 0.4% of the WGS variants. The vast majority of variants called by WES or WGS had a GQ close to 100.
However, the proportion of variants called by WES with a GQ < 20 (3.1%) was, on average, twice that for WGS (1.3%) ( Fig. 1B) . MRR followed a similar overall distribution for WES and WGS heterozygous variants, but peaks corresponding to values of MRR of 1/7, 1/6, 1/5 and 1/4 were detected only for the WES variants (Fig. 1C) . These peaks probably corresponded mostly to variants called at a position covered by only 7, 6, 5 and 4 reads, respectively. The overall distributions of these parameters indicated that the variants detected by WGS were of higher and more uniform quality than those detected by WES.
Next, we looked specifically at the distribution of these parameters for the variants with genotypes discordant between WES and WGS, denoted as discordant variants. The distribution of CD for WES variants showed that most discordant variants had low coverage, at about 2X, with a CD distribution very different from that of concordant variants (Fig. S2A) . Moreover, most discordant variants had a GQ < 20 and a MRR < 0.2 for WES ( Fig. S2B) . By contrast, the distributions of CD, GQ, and MRR were very similar between WGS variants discordant with WES results and WGS variants concordant with WES results (Fig. S2) . All these results indicate that the discordance between the genotypes obtained by WES and WGS was largely due to the low quality of WES calls for the discordant variants. We therefore conducted subsequent analyses by filtering out low-quality variants. We retained SNVs with a CD ≥ 8X and a GQ ≥ 20, as previously suggested (17) , and with a MRR ≥ 0.2. Overall, 93.8% of WES variants and 97.8% of WGS variants satisfied the filtering criterion ( Fig. 2A) . We recommend the use of these filters for projects requiring high-quality variants for analyses of WES data.
More than half (57.7%) of the WES variants filtered out were present in the flanking 50 bp regions, whereas fewer (37.6%) of the WGS variants filtered out were present in these regions.
In addition, 141 filtered WES variants and 70 filtered WGS variants per sample concerned the two base pairs adjacent to the exons, which are key positions for splicing. However, complete removal of the 50 bp flanking regions from the initial calling would result in a large decrease (~90,000) in the number of fully included protein coding exons (Table S1 ). After filtering, the two platforms called an average of 76,195 total SNVs per sample, and the mean proportion of variants for which the same genotype was obtained with both techniques was 99.92% (range: 99.91%-99.93%).
We then studied the high-quality (HQ) variants satisfying the filtering criterion but called by only one platform. On average, 2,734 variants (range: 2,344-2,915) were called by WES but not by WGS ( Fig. 2A) , and 6,841 variants (range: 5,623-7,231) were called by WGS but not WES ( Fig. 2A) . We used Annovar software (18) to annotate these HQ variants as coding variants, i.e., variants overlapping a coding exon, that refers only to coding exonic portion, but not UTR portion. Overall, 651 of the 2,734 WES-exclusive HQ variants and 1,113 of the 6,841 WGSexclusive HQ variants were coding variants ( Fig. 2A) . Using the Integrative Genomics Viewer (IGV) tool (19), we noticed that most WES-exclusive HQ variants were also present on the WGS tracks with quality criteria that were above our defined thresholds. We were unable to determine why they were not called by the Unified Genotyper. We therefore used the GATK (Fig. 2B) . The quality and distribution of CD, GQ and MRR obtained with this combined calling process were similar to those previously reported for Unified Genotyper (Fig. S3) .
We further investigated the HQ coding variants called exclusively by one method when a combination of the two callers was used. We were able to separate the variants identified by only one technique into two categories: 1) those called by a single method and not at all by the other, which we refer to as fully exclusive variants, and 2) those called by both methods but filtered out by one method, which we refer to as partly exclusive variants. Of the HQ coding variants identified by WES only (105, on average, per sample), 61% were fully exclusive and 39% were partly exclusive. Of those identified by WGS only (692, on average) 21% were fully exclusive and 79% were partly exclusive. We performed Sanger sequencing on a random selection of 170 fully and partly exclusive WES/WGS variants. Out of 44 fully exclusive WES variants successfully Sanger sequenced, 40 (91%) were absent from the true sequence, indicating that most fully exclusive WES variants were false positives ( Table 1 and Table S3 ).
In contrast, 39 (75%) of the 52 Sanger-sequenced fully exclusive WGS variants were found in the sequence, with the same genotype as predicted by WGS (including 2 homozygous), and 13 (25%) were false positives ( Table 1 and Table S3 ). These results are consistent with the observation that only 27.2% of the fully exclusive WES variants were reported in the 1000 genomes database (20), whereas most of the fully exclusive WGS variants (84.7%) were present in this database, with a broad distribution of minor allele frequencies (MAF) ( Fig.   S4A ). Similar results were obtained for the partly exclusive variants. Only 10 (48%) of the 21 partly exclusive WES variants (including 3 homozygous) were real, whereas all (100%) of the 24 partly exclusive WGS variants (including 8 homozygous) were real. Using these findings, we estimated the overall numbers of false-positive and false-negative variants detected by these two techniques. WES identified a mean of 26 real coding variants per sample (including 5 homozygous) that were missed by WGS, and a mean of 79 false-positive variants. WGS identified a mean of 656 real coding variants per sample (including 104 homozygous) that were missed by WES, and a mean of 36 false-positive variants.
We noted that most of the false-positive fully exclusive WGS variants were located in the three genes (ZNF717, OR8U1, and SLC25A5) providing the largest number of exclusive variants on WGS (Table S4 ). Further investigations of the reads corresponding to these variants on the basis of blast experiments strongly suggested that these reads had not been correctly mapped ( Table 2) . Overall, we found that the majority of false positive WGS fully exclusive variants (11/13) and only a minority of false positive WES fully exclusive variants (4/40) could be explained by alignment and mapping mismatches ( Table 2) . We then determined whether the exclusive WES/WGS variants were likely to be deleterious and affect the search for diseasecausing lesions. The distribution of combined annotation-dependent depletion (CADD) scores (21) for these variants is shown in Fig S4B. About 38.6% of the partly exclusive WES variants and 29.9% of the partly and fully exclusive WGS variants, which were mostly true positives, had a phred CADD score > 10 (i.e. they were among the 10% most deleterious substitutions possible in the human genome), and might include a potential disease-causing lesion. We found that 54.6% of fully exclusive WES variants, most of which were false positives, had a phred CADD score > 10, and could lead to useless investigations. Finally, we investigated whether some genes were particularly poorly covered by WES despite being targeted by the kit we used, by determining, for each sample, the 1,000 genes (approximately 5% of the full set of genes) with the lowest WES coverage ( Fig. S5) . Interestingly, 75.1% of these genes were common to at least four samples (of 6), and 38.4% were present in all six individuals. The percentage of exonic base pairs (bp) with more than 8X coverage for these 384 genes was, on average, 73.2% for WES (range: 0%-86.6%) and 99.5% for WGS (range: 63.6%-100%) ( Table S5 ). These genes with low WES coverage in all patients comprised 47 genes underlying Mendelian diseases, including EWSR1, the causal gene of Ewing sarcoma, three genes (IMPDH1, RDH12, NMNAT1) responsible for Leber congenital amaurosis, and two genes (IFNGR2, IL12B) responsible for Mendelian susceptibility to mycobacterial diseases (Table S5 ).
Discussion
These results demonstrate that WGS can detect hundreds of potentially damaging coding variants per sample of which ~16% are homozygous, including some in genes known to be involved in Mendelian diseases, that would have been missed by WES in the regions targeted by the exome kit. In addition to the variants missed by WES in the targeted regions, a large number of genes, protein-coding exons, and non-coding RNA genes were not investigated by WES despite being fully sequenced by WGS ( Fig. 3) . Finally, mutations outside protein-coding exons, or not in exons at all, might also affect the exome covered by WES, as mutations in the middle of long introns might impair the normal splicing of the exons (22). These mutations would be missed by WES, but would be picked up by WGS (and selected as candidate mutations if the mRNAs were studied in parallel, for example by RNAseq). The principal factors underlying the heterogeneous coverage of WES are probably related to the hybridization/capture and PCR amplification steps required for the preparation of sequencing libraries for WES (23). Here, we clearly confirmed that WGS provides much more uniform distribution of sequencing quality parameters (CD, GQ, MRR) than WES, as recently reported (12) . In addition, we performed Sanger sequencing on a large number of variants to obtain a high-resolution estimate of the number of false positives and false negatives in both WES and WGS ( Fig. 3) . We further showed that a number of false-positive results, particularly for the WGS data, probably resulted from mapping problems. We also carried out a detailed characterization of the variants and genes for which the two methods yielded the most different results, providing a useful resource for investigators trying to identify the most appropriate sequencing method for their research projects. Further studies will explore whether similar results are also obtained for other types of variants (e.g. indels, CNVs). We provide open access to all the scripts used to perform this analysis at the software website GITHUB (https://github.com/HGID/WES_vs_WGS). We hope that researchers will find these tools helpful for analyses of data obtained by WES and WGS, two techniques that will continue to revolutionize human genetics and medicine.
Material and Methods

Study subjects:
The six subjects for this study (four females, two males) were collected in the context of a project on Isolated Congenital Asplenia (24). They were all of Caucasian origin (two from USA, and one from Spain, Poland, Croatia, and France), and unrelated. This study was conducted under the oversight of the Rockefeller University IRB. Written consent was obtained from all patients included in this study.
High-throughput Sequencing:
DNA was extracted from the ficoll pellet of 10mL of blood in heparin tubes. Four to six µg of unamplified, high molecular weight, RNase treated genomic DNA was used for WES and WGS. WES and WGS were done at the New York Genome Center (NYGC) using an Sequencing was done with the aim of 30X coverage from 2x100bp paired-end reads.
Analysis of high-throughput sequencing data:
We used the Genome Analysis Software Kit (GATK) best practice pipeline to analyse our WES and WGS data (13) . Reads were aligned to the human reference genome (hg19) using the Maximum Exact Matches algorithm in Burrows-Wheeler Aligner (BWA) (25). Local realignment around indels was performed by the GATK (14) . PCR duplicates were removed using Picard tools (http://picard.sourceforge.net). The GATK base quality score recalibrator was applied to correct sequencing artefacts. We called our 6 WES simultaneously together with 24 other WES using Unified Genotyper (UG) (14) as recommended by the software to increase the chance that the UG calls variants that are not well supported in individual samples rather than dismiss them as errors. All variants with a Phred-scaled SNP quality ≤ 30 were filtered out. The UG calling process in WGS was similar to that used for WES; we called our 6 WGS together with 20 other WGS. In both WES and WGS, the calling process targeted only regions covered by the WES 71 Mb kit + 50bp flanking each exon (12) . When we expanded the WES regions with 100 and 200 bp flanking each exon as performed in some previous studies (26-30), we observed a higher genotype mismatch in variants called by WES and WGS, with a much lower quality of the WES variants located in those additional regions.
Matched and mismatched genotype statistics, analyses of variant coverage depth (CD), i.e. the number of reads passing quality control used to calculate the genotype at a specific site in a specific sample, genotype quality (GQ), i.e. a phred-scaled value representing the confidence that the called genotype is the true genotype, and minor read ratio (MRR), i.e. the ratio of reads for the less covered allele (reference or variant allele) over the total number of reads covering the position where the variant was called, were performed using a homemade R software script (31).
We then filtered out variants with a CD < 8 or GQ < 20 or MRR < 20% a suggested in (17) using a homemade script .We used the Annovar tool (18) to annotate high quality (HQ) variants that were detected exclusively by one method. We checked manually some HQ coding variants detected exclusively by WES or WGS using the Integrative Genomics Viewer (IGV) (19), and we observed that some HQ coding WES exclusive variants, were also present in WGS but miscalled by the UG tool. To recall the UG miscalled SNVs, we used the GATK haplotype caller tool (HC) (14) . Indels and SNVs were called simultaneously on 6 WES and 6 WGS, and SNV calls were extracted. The same DP, GQ and MRR filters were applied, and we used Annovar to annotate the HQ resulting variants. All scripts are available on https://github.com/HGID/WES_vs_WGS.
Sanger sequencing:
We randomly selected variants detected exclusively by WES or WGS to test them by Sanger sequencing. We chose more variants in the two categories of WES fully-exclusive and WGS fully-exclusive as we first hypothesized (wrongly) that most, if not all, partly-exclusive variants would be real. We chose less variants in sample S1, as we had few gDNA available for this sample, and we could not test any of the variants in S2 because of absence of remaining gDNA. No other criteria (position, gene, CADD score, frequency) was used for deciding which variants to Sanger sequence. The design of the primers and the sequencing technique are described in Table S3 .
Analysis of the Sanger sequences was done using the DNASTAR SeqMan Pro software (v11.2.1) using the default settings. To facilitate the localization of the potential variants, we assembled the sequences obtained by Sanger with a 20bp fasta sequence centered on each variant. This sequence was obtained by creating a bed file of the region in the same way as described for the primer design (Table S3 ). Variants where either the forward or reverse sequence did not work were excluded from the analysis and assigned a NA on the Sanger sequencing results Table S3 . Sanger sequencing was only attempted once for each variant using the conditions described above. * : Estimated numbers of real variants and false positives were computed on the basis of real and false positives proportions applied on the average number of variants per sample  : 1 real WGS fully exclusive variant was homozygous in Sanger and called heterozygous by WGS Table S3 ), were aligned using Blast (32) to the reference genome (hg19).  : Number of variants with all reads mapping to a single region using Blast with default parameters (the threshold for identifying a mapped region is 80% of identities with the blasted sequence). ‡ : Number of variants with all reads mapping to 1) the initial region assigned by the WES or WGS analysis, and 2) at least another region with a higher alignment score (comprised between 95 and 100% of identities). 
Figure 1: Distribution of the three main quality parameters for the variants detected by WES or WGS: (A)
Supplementary text:
Sanger sequencing methods
Design of the primers: The first step was to create a bed file with each row representing a region of 400bp centered on the variants chosen for Sanger sequencing. The bed file was then uploaded in the UCSC genome browser using the 'add custom tracks' tab. The reference genome assembly used was GRCh37/hg19 (https://genome.ucsc.edu/cgi-bin/hgGateway).
Fasta files with the sequence for each region were then downloaded from the UCSC website, and uploaded to BatchPrimer3 v1.0 (http://batchprimer3.bioinformatics.ucdavis.edu/cgibin/batchprimer3/batchprimer3.cgi) (1) . We noticed that BatchPrimer3 worked better if the fasta files were copied and pasted rather uploaded using a link. We then requested for Sequencing primers using the following parameters: nb of return = 1 (1 towards 3', and 1 Four types of genomic units were analyzed: protein-coding exons, miRNA exons, snoRNA exons, and lincRNA exons as defined in Ensembl Biomart (2) . We determined the number of these units using the R Biomart package (3) on the GRCh37/hg19 reference. For the counts, we excluded one of the duplicated units of the same type, or units entirely included in other units of the same type (only the longest unit would be counted in this case). We then determined the number of the remaining units that were fully or partly covered when considering the genomic regions defined by the Agilent Sure Select Human All Exon kit 71Mb (v4 + UTR) with or without the 50 bps flanking regions. GRIN2D  5  3  SGK2  4  1KALRN  5  3  ATF7IP  3  1NAV2  5  3  ATRNL1  3  1NBPF3  5  3  BCOR  3  1TG  5  3  C19orf44  3  1ZAN  5  3  DDX18  3  1DPP3  4  3  DYSF  3  1FRY  4  3  FAM135A  3  1HLA--DRB5  4  3  FMN1  3  1HMMR  4  3  FRMD4A  3  1KIAA1211  4  3  FRYL  3  1MRS2  4  3  HIPK4  3  1PCNT  4  3  MAP2K3  3  1PKD1L1  4  3  MDGA2  3  1SOHLH1  4  3  MITF  3  1TMEM158  4  3  MUC16  3  1BAHCC1  3  3  NKX2--8  3  1C8orf73  3  3  OTUD4  3  1CCDC57  3  3  OXCT2  3  1CYP2A7  3  3  SELRC1  3  1DRD4  3  3  SLC35E2  3  1FHOD3  3  3  SLC5A12  3  1GAB4  3  3  SPTA1  3  1LILRB3  3  3  TICRR  3  1LOC653486  3  3  UBE2D1  3  1LRP8  3  3  USH2A  3  1MED16  3  3  USP49  3  1MUC12  3  3  WFDC1  3  1PDE4DIP  3  3  ADCY8  2  1PILRB  3  3  AKAP1  2  1SLC16A8  3  3  ALPPL2  2  1SORT1  3  3  AQP2  2  1TMED8  3  3  ATP6V1A  2  1TMEM44  3  3  BCL9  2  1CCDC61  2  3  C1orf94  2  1CD200R1  2  3  C2CD3  2  1CD24  2  3  C5orf60  2  1GPR31  2  3  CACNA1S  2  1 HLA--DQB1 2 3 CATSPERG 2 1
LGALS8 2  3  CCAR1  2  1MMP20  2  3  CHRNA4  2  1OR2T4  2  3  CNTD1  2  1PEX6  2  3  CRTAC1  2  1PIEZO1  2  3  CYB561  2  1PPP1R37  2  3  DERA  2  1PRR5  2  3  DOCK5  2  1TCF3  2  3  FAM13A  2  1TMEM86B  2  3  FAT2  2  1TRIM50  2  3  FKRP  2  1UHRF1  2  3  FOXK1  2  1ZFPM1  2  3  GCGR  2  1CACNA1B  1  3  GEMIN2  2  1CHGA  1  3  GPATCH8  2  1GABBR1  1  3  HMCN1  2 
